9 Heart Attack Clinical Trials in Hartford, CT (2026)

Q: How do I join a clinical trial in Hartford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you.

Recruiting Heart Attack Studies in Hartford

NCT06289985Recruiting

StrokeNet Thrombectomy Endovascular Platform

STEP is a Randomized, Multifactorial, Adaptive Platform trial that seeks to optimize the care of patients with acute ischemic stroke (AIS) due to large (LVO) or medium vessel occlusions (MVO)....

Hartford, CTNA1,600 participantsMedical University of South Carolina

View Study Details

NCT02677064Recruiting

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get ...

Hartford, CT1,365 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07007312Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Ziftomenib is an investigational drug in development for the treatment of patients with acute myeloid leukemia (AML) with eligible genetic alterations. Ziftomenib is a type of therapy known to target ...

Hartford, CTPHASE31,300 participantsKura Oncology, Inc.

View Study Details

NCT03242642Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device....

Hartford, CTNA1,056 participantsMedtronic Cardiovascular

View Study Details

NCT03911700Recruiting

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hern...

Hartford, CTNA477 participantsC. R. Bard

View Study Details

NCT04968834Recruiting

Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy

This research study is a genomic profiling and repository study for children and young adults who have leukemia, myelodysplastic syndrome (MDS) or myeloproliferative syndrome (MPS). Genes are the part...

Hartford, CT300 participantsDana-Farber Cancer Institute

View Study Details

NCT05948566Recruiting

Strategy for Improving Stroke Treatment Response

SISTER is a Phase-II, prospective, randomized, placebo-controlled, blinded, dose finding trial that aims to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alp...

Hartford, CTPHASE2300 participantsTranslational Sciences, Inc.

View Study Details

NCT05203965Recruiting

Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

The purpose of this study is to evaluate the role of Mavoglurant in clarifying the neurobiology of alcoholism risk. This is a one-site, randomized, within subjects, counterbalanced double-blind study ...

Hartford, CTEARLY_PHASE180 participantsYale University

View Study Details

NCT05972018Recruiting

Liposomal Bupivacaine/Bupivacaine in Rectus Sheath Blocks Versus Ropivacaine in Rectus Sheath Blocks And Catheters

The goal of this pilot study is to compare single shot rectus sheath blocks of liposomal bupivacaine/bupivacaine mixture to bilateral rectus sheath catheters infused with ropivacaine (standard of care...

Hartford, CTPHASE414 participantsHartford Hospital

View Study Details

About Heart Attack Clinical Trials in Hartford

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 9 heart attack clinical trials recruiting participants in Hartford, CT. These studies are seeking a combined 6,492 participants. Research is being sponsored by Medical University of South Carolina, Memorial Sloan Kettering Cancer Center, Kura Oncology, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Hartford — FAQ

Are there heart attack clinical trials in Hartford?

Yes, there are 9 heart attack clinical trials currently recruiting in Hartford, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hartford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hartford research site will contact you about next steps.

Are clinical trials in Hartford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hartford studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 9 active trials in Hartford are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 17, 2026 from ClinicalTrials.gov